Session Details

[1AT1-14]11. Biotechnology, Frontier Sciences and Evolution Ⅰ

Tue. Dec 1, 2026 9:00 AM - 11:00 AM JST
Tue. Dec 1, 2026 12:00 AM - 2:00 AM UTC
Room 14 (Conference Center 4F 419)
Chairs: Takashi Shimokawa (QST), Fumihito Miura (The University of Tokyo)
Presentation Time: 10 minutes (8 minutes for the presentation, 1 minute 30 seconds for discussion, and 30 seconds for transition)

[1AT1-14-01(1P-0701)]Adaptive Immune Receptor Repertoires (AIRRs) Link Individual Stimulus Responses with Pooled Genetic Variance

○Steven Matthew Heaton1, Shohei Kojima1,2, Miki Kojima1, Tomoko Kasahara1, Hiromi Sano1, Fumie Yokoyama1, Anselmo Jiro Kamada1,3, Rie Koide1, Asami Fujii Gelinas1, Takashi Watanabe1, Chikashi Terao1, Yoshinari Ando1, Kokoro Ozaki1, Yasuhiro Murakawa1, Nicholas Fredrick Parrish1,4 (1. RIKEN, 2. Keio University, 3. University of Oxford Department of Biology, 4. Duke University Department of Surgery)
Comment()

[1AT1-14-02(1P-0674)]Deep Learning-Based Design of Synthetic Enhancers Specific to Cross-Resistant Cells in Malignant Melanoma

○Ken Murakami1, Tobias Beschauner1, Anna Obenauf1, Alexander Stark1,2 (1. Research Institute of Molecular Pathology, 2. Medical University of Vienna)
Comment()

[1AT1-14-03(1P-0712)]Structural insight into IscB’s RNA-lid-based inactivation mechanism

○Feizuo Wang1, Chunyi Hu1 (1. National University of Singapore)
Comment()

[1AT1-14-04(1P-0747)]Monitoring in vivo transcription with synthetic serum markers

○Sho Watanabe1, Jerzy Szablowski1 (1. Rice University)
Comment()

[1AT1-14-05(1P-0703)]Division state identifies dynamic genetic regulation during T-cell activation and immune disease-linked gene programmes

○Kyuto Sonehara1, Megan Gozzard1, Kevin Ly1, Tarran S. Rupall1, Ziying Ke1, Mohammad Lotfollahi1, Blagoje Soskic2, Carla P. Jones1, Olivier B. Bakker1, Gosia Trynka1 (1. Wellcome Sanger Institute, 2. Human Technopole)
Comment()

[1AT1-14-06(1P-0749)]Deep Learning-Assisted Fluorescent Sensor System of Cross-Responsive Living Bacteria for Multi-Analyte Quantification

○Siratchakrit Shinnakerdchoke1, Yasuda Takanobu2, Zhu Bo2,3, Kitaguchi Tetsuya2 (1. LST, Institute of Science Tokyo, Kanagawa, Japan, 2. CLS, IIR, Institute of Science Tokyo, Kanagawa, Japan, 3. Department of Life Science, Faculty of Advanced Engineering, Chiba Institute of Technology, Chiba, Japan)
Comment()

[1AT1-14-07 →演題取下げ Withdraw]Withdraw

Comment()

[1AT1-14-08(1P-0706)]Development of a turn-ON type proximity labeling method and application to mitochondrial membrane proteins

○Takumi Kariya1, Shinichi Sato2,3, Keita Nakane2,3, Mikiko Sodeoka1, Kosuke Dodo1 (1. RIKEN CSRS, 2. FRIS, Univ. of Tohoku, 3. Grad. Sch., Life Sciences, Univ. of Tohoku)
Comment()

[1AT1-14-09(2P-0744)]Multiscale TEM/CLEM mapping of the gastric squamous-columnar junction

○Marielle Fernandez Bandalan1, Ea Kristine Clarisse Tulin2, Takashi Tonozuka1, Atsushi Nishikawa1, Takuma Kozono1 (1. Tokyo University of Agriculture and Technology, 2. Visayas State University)
Comment()

[1AT1-14-10(1P-0740)]Mechanistic Basis of Recognition-Driven Target Selectivity of a Lysine-Directed Covalent Allosteric SHP2 Inhibitor

○Takeru Hayashi1, Miki Senda2, Wataru Ikeda3, Takuya Ooki1, Yui Yamamoto1, Keiji Tanino3, Toshiya Senda2, Masanori Hatakeyama1 (1. Inst. of Microbial Chem. (BIKAKEN), 2. KEK, 3. Hokkaido Univ.)
Comment()

[1AT1-14-11(1P-0685)]Cross-Disease Therapeutic Target Discovery through Machine Learning Integrating Genomic and Transcriptomic Information

○Satoko Namba1,2, Michio Iwata3, Shin-Ichi Nureki4, Noriko Yuyama Otani2, Yoshihiro Yamanishi2,5 (1. Nagoya Univ., 2. Grad. Sch. of Informatics, Complex Syst. Sci., Nagoya Univ., 3. Fac. Comput. Sci. Syst. Eng., Biosci. Bioinform., Kyushu Inst. Technol., 4. Fac. Med., Respir. Med. Infect. Dis., Oita Univ., 5. Interdiscip. Res. Dev. Div., Aichi Cancer Cent. Res. Inst.)
Comment()

[1AT1-14-12(1P-0734)]Collagen-binding IL-12 armoured, STEAP1-targeting CAR-T cells for prostate cancer

○Koichi Sasaki1, Vipul Bhatia2,3, Yuta Asano4, Jakob Bakhtiari4, Pooja Kaur1, Chuyi Wang1, Takumi Matsuo1, Olivier Dubois1, Po-Chuan Chiu1, Donny Gun5, Charanjit Singh1, Ioanna Panagi1, Laurine Noblecourt1, Maria Nikolaidi1, Truman Chong3, Gerardo Javier2,3, Saul J Priceman6,7, Aude G Chapuis4,8, John K Lee2,3,9, Jun Ishihara1,10 (1. Dept. Bioengineering, Imperial College London, 2. Human Biology Div. Fred Hutchinson Cancer Center, 3. Dept. Medicine, David Geffen Sch. of Med., UCLA, 4. Translational Science and Therapeutics Div. Fred Hutchinson Cancer Center, 5. Dept. Microbiology, Immunology and Molecular Genetics, UCLA, 6. Dept. Hematology and Hematopoietic Cell Transplantation, City of Hope, 7. Dept. Immuno-Oncology, Beckman Research Institute, City of Hope, 8. Div. Medical Oncology, Uni. of Washington, 9. Parker Institute for Cancer Immunotherapy, UCLA, 10. Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center)
Comment()